Efstathios Kastritis
- Hematology top 0.05%
- Multiple Myeloma Research and Treatments 318
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research 106
- Myeloproliferative Neoplasms: Diagnosis and Treatment 43
- Oncology top 0.2%
- Peptidase Inhibition and Analysis 75
- Cancer Treatment and Pharmacology 54
- Nephrology top 0.5%
- Orthopedics and Sports Medicine top 0.5%
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 164
- Protein Degradation and Inhibitors 81
-
- Lymphoma Diagnosis and Treatment 45
- Co-authors
- Meletios Α. DimopoulosEvangelos TerposMaria GavriatopoulouIoannis Ntanasis‐StathopoulosΜαρία ΡούσσουDimitra GikaΘεοδώρα ΨαλτοπούλουDespina Fotiou
- Cited by
- HematologyGeneticsOncology
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (27 papers)SHILAP Revista de lepidopterología (6 papers)
- Partner nations
- GreeceUnited StatesItaly
In The Last Decade
Efstathios Kastritis
541 papers receiving 14.7k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Hematology 5.5k
- Genetics 3.1k
- Oncology 5.7k
- Nephrology 1.2k
- Orthopedics and Sports Medicine 1.3k
Countries citing papers authored by Efstathios Kastritis
This map shows the geographic impact of Efstathios Kastritis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Efstathios Kastritis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Efstathios Kastritis more than expected).
Fields of papers citing papers by Efstathios Kastritis
This network shows the impact of papers produced by Efstathios Kastritis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Efstathios Kastritis. The network helps show where Efstathios Kastritis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Efstathios Kastritis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 5 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 9 | |
| 15 | 2022 | 21 | |
| 16 | 2022 | 1 | |
| 17 | 2021 | 11 | |
| 18 | 2020 | 49 | |
| 19 | 2017 | 47 | |
| 20 | Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus. | 2014 | 0 |
About Efstathios Kastritis
Efstathios Kastritis is a scholar working on Hematology, Genetics and Oncology, having authored 583 papers that have together received 15.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (318 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (164 papers), Chronic Lymphocytic Leukemia Research (106 papers), Protein Degradation and Inhibitors (81 papers), Peptidase Inhibition and Analysis (75 papers), Cancer Treatment and Pharmacology (54 papers), Lymphoma Diagnosis and Treatment (45 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (43 papers). The work is most often cited by research in Hematology (5.5k citations), Genetics (3.1k citations) and Oncology (5.7k citations). Efstathios Kastritis has collaborated with scholars based in Greece, United States and Italy. Frequent co-authors include Meletios Α. Dimopoulos, Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Μαρία Ρούσσου, Dimitra Gika, Θεοδώρα Ψαλτοπούλου, Despina Fotiou, Magdalini Migkou and Giampaolo Merlini. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.